Parathyroid Allotransplantation: Report of Outcomes in 3 Patients.

Background: Hypoparathyroidism is a relatively rare endocrine disorder defined as inadequate parathyroid hormone (PTH) secretion leading to a clinical syndrome characterized by hyperphosphatemia and hypocalcemia. This condition has high morbidity; patients present with a heterogeneous range of emotional, mental, and physical symptoms. We present our experience with PTH transplantation, using parathyroid glands surgically removed in the setting of secondary hyperparathyroidism, with a description of the clinical course, immunosuppressive management, and surgical technique.

Obesity and Kidney Transplantation-How to Evaluate, What to Do, and Outcomes.

Obesity is a growing issue that is spreading worldwide; its prevalence is ever increasing in patients with end-stage renal disease and represents a potential barrier to transplantation. The lack of unanimous guidelines exacerbates the current disparity in treatment, which can affect outcomes, leading to a significantly longer time on the waiting list. Multidisciplinary and multimodal management (encompassing several healthcare professionals such as nephrologists, transplant physicians and surgeons, primary care providers, and nurses) is of paramount importance for the optimal management of this patient population in a continuum from waitlisting to transplantation.

Desensitizing With Temporary Donor Splenic Transplant: Hope for the Sensitized Patients on Pancreas and Kidney -Pancreas Transplant Waitlist.

Background: Sensitized patients on a waitlist with donor specific antibodies (DSA) or positive flow cytometry cross match (FXM) to deceased donor organ have few pretransplant desensitization options due to increasing graft cold ischemia time. Herein, sensitized simultaneous kidney/pancreas recipients received temporary splenic transplant from the same donor under the hypothesis that spleen would function as a DSA graveyard and provide a safe immunologic window for transplant.

Methods: We analyzed presplenic and postsplenic transplant FXM and DSA results of 8 sensitized patients who underwent simultaneous kidney and pancreas transplantation with temporary deceased donor spleen between November 2020 and January 2022.

Corrigendum: Donor Size Doesn't Impact Kidney Transplant Outcomes: A Single-Center Experience and Review of Literature.

[This corrects the article DOI: 10.3389/ti.2022.

Donor Size Doesn't Impact Kidney Transplant Outcomes: A Single-Center Experience and Review of Literature.

Few transplant programs use kidneys from donors with body weight (BW)<10 kg due to higher incidence of vascular and urological complications, and DGF. The purpose of this study was to investigate the non-inferiority of pediatric kidneys from donors with BW<10 kg. We performed a single-center retrospective analysis of kidney transplants from pediatric donor cohort ( = 46) from 2003 to 2021 and stratified the outcomes by donor BW (small group, donor BW<10 kg, = 30; standard group, donor BW<10 kg, = 16).

Lasting Over Time: 20-Year Follow-Up of Living Related Simultaneous Pancreas-Kidney Transplant Between Identical Twins.

Background: Twenty-year follow-up of the first reported simultaneous pancreas-kidney transplant from living donor between identical twins.

Case: We present a case of a patient after the world's first simultaneous pancreas and kidney transplant between identical twins. The transplant was performed because of diabetes mellitus type (DM1) related renal failure.